The use of new technologies of diagnostics for the detection of hereditary metabolic diseases
Abstract
Application of new diagnostic technologies for early detection of hereditary metabolic diseases revealed their significant advantages (high analytical specificity and sensitivity, high bandwidth) and the appropriateness of their use in neonatal screening. Decrease of the number of false positive results, one definition of a large number of biochemical markers in a minimum quantity of biological sample made it possible to reduce the total duration of laboratory research and to ensure high performance diagnostic process. However, the lack of specificity of the markers requires to use molecular-genetic research as a supporting method of diagnosis. Speed of execution, the relative low cost, relatively simple interpretation of the obtained results of high-performance next-generation sequencing (NGS) allowed to recommend it as a the final stage of diagnosis of neonatal screening.
About the Authors
Y. A. Churyumova
St. Petersburg State municipal health care institution» Diagnostic (medical genetics); V.A. Almazov Federal North-West Medical Research Centre
Russian Federation
Russian Federation
N. V. Vokhmyanina
St. Petersburg State municipal health care institution» Diagnostic (medical genetics)
Russian Federation
Russian Federation
References
1. Chace DH, Hannon WH. Impact of second-tier testing on the effectiveness of newborn screening.Clin Chem. 2010 Nov;56(11):1653-5.
2. Jicheng Q, Xiaonan W, Jia L, et al. Applying targeted next generation sequencing to dried blood spot specimens from suspicious cases identified by tandem mass spectrometry-based newborn screening. J Pediatr Endocrinol Metab. 2017 Aug 28;30(9):979-988.
3. Solomon BD, Pineda-Alvarez DE, Bear KA, etal. NISC Comparative Sequencing Program Applying Genomic Analysis to Newborn Screening Mol Syndromol. 2012 Aug;3(2):59-67.
4. Lin X, Tang W, Ahmad S, et al. Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities. Hear Res. 2012 Jun;288(1-2):67-76.
5. Bhattacharjee A, Sokolsky T, Wyman SK, et al. Development of DNA confirmatory and high-risk diagnostic testing for newborns using targeted next-generation DNA sequencing. Genet Med. 2015 May;17(5):337-47.
6. Воскобоева Е.Ю., Байдакова Г.В., Денисенков А.И., Денисенкова Е.В., Захарова Е.Ю. Галактоземия в России: Молекулярно-генетические особенности, неонатальный скрининг, подтверждающая диагностика. Медицинская генетика Т.8, №6, 2009; 25-33.
7. Байдакова Г.В., Захарова Е.Ю., Канивец И.В., Коновалов Ф.А., Стрельников В.В., Куцев С.И.Диагностика врожденных и наследственных болезней у детей: достижения и перспективы развития. Вестник Росздравнадзора №3, 2016; С. 27-33.
Review
For citations:
Churyumova Y.A., Vokhmyanina N.V. The use of new technologies of diagnostics for the detection of hereditary metabolic diseases. Medical Genetics. 2017;16(10):18-22. (In Russ.)
Views:
502
Email this article 